Staphylococcus aureus is the leading cause of secondary infections in hospitals and a challenging pathogen in food industries. Decades after it was first reported, β-lactam-resistant S. aureus remains a subject of intense research owing to the ever-increasing issue of drug resistance. S. aureus bacteriophages (phages) or their encoded products are considered an alternative to antibiotics as they have been shown to be effective in treating some S. aureus-associated infections. In this review, we present a concise collection of the literature on the pathogenic potential of S. aureus and examine the prospects of using S. aureus phages and their encoded products as antimicrobials.

金黄色葡萄球菌是医院继发感染的主要原因，也是食品工业中具有挑战性的病原体。在首次报道几十年后，由于耐药性问题的不断增加，耐 β-内酰胺的金黄色葡萄球菌仍然是一个深入研究的主题。金黄色葡萄球菌噬菌体（噬菌体）或其编码产物被认为是抗生素的替代品，因为它们已被证明可有效治疗一些金黄色葡萄球菌相关感染。在这篇综述中，我们简要收集了有关金黄色葡萄球菌致病潜力的文献，并探讨了使用金黄色葡萄球菌噬菌体及其编码产物作为抗菌剂的前景。